| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |